TrialCardiovascular journal of Africa

Long-term safety and efficacy of alirocumab in South African patients with heterozygous familial hypercholesterolaemia: the ODYSSEY Open-Label Extension study.

Dirk J Blom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.